Market revenue in 2023 | USD 80.4 million |
Market revenue in 2030 | USD 185.5 million |
Growth rate | 12.7% (CAGR from 2023 to 2030) |
Largest segment | Companion animals |
Fastest growing segment | Companion Animals |
Historical data covered | 2018 - 2022 |
Base year for estimation | 2023 |
Forecast period covered | 2024 - 2030 |
Quantitative units | Revenue in USD million |
Market segmentation | Companion Animals, Production Animals |
Key market players worldwide | Zoetis, Virbac SA, Merck & Co Inc, IDEXX Laboratories Inc, Avacta Group PLC, Life Diagnostics, Mercodia, Antech Diagnostics |
No credit card required*
Name | Profile | # Employees | HQ | Website |
---|
The databook is designed to serve as a comprehensive guide to navigating this sector. The databook focuses on market statistics denoted in the form of revenue and y-o-y growth and CAGR across the globe and regions. A detailed competitive and opportunity analyses related to veterinary biomarkers market will help companies and investors design strategic landscapes.
Companion animals was the largest segment with a revenue share of 61.57% in 2023. Horizon Databook has segmented the Latin America veterinary biomarkers market based on companion animals, production animals covering the revenue growth of each sub-segment from 2018 to 2030.
Horizon Databook provides a detailed overview of continent-level data and insights on the Latin America veterinary biomarkers market , including forecasts for subscribers. This continent databook contains high-level insights into Latin America veterinary biomarkers market from 2018 to 2030, including revenue numbers, major trends, and company profiles.
Sign up and get instant basic access to databook, upgrade
when ready, or enjoy our
free plan indefinitely.
Included in Horizon account